Categories AlphaGraphs, Earnings, Health Care

A visual representation of Pfizer Inc. (NYSE: PFE) Q1 2020 earnings results

Pfizer Inc. (NYSE: PFE) Tuesday reported a decline in first-quarter earnings and revenues. However, the results exceeded analysts’ forecast.

Pfizer Inc. Q1 2020 earnings infographic

Earnings, on an adjusted basis, dropped to $0.80 per share from $0.85 per share in the first quarter of 2019. The pharma company reported unadjusted profit of $3.4 billion or $0.61 per share for the three-month period, down from last year’s $3.88 billion or $0.68 per share. Earnings, meanwhile, came in above the estimates.

The weakens in the bottom-line performance is attributable to a 8% decline in revenues to $12 billion. Analysts were looking for a slightly lower number.

Shares of Pfizer closed the last trading session higher and continued to gain during Tuesday’s pre-market session. The stock has declined 7% in the past twelve months.

Also Read:  Pfizer Inc (NYSE: PFE) Q4 2019 Earnings Call Transcript

Most Popular

Novavax (NVAX) stock tumbles despite beating bottom line estimates in Q2

After Novavax (NASDAQ: NVAX) reported its progress on developing the COVID-19 vaccine at the end of February, the shares of the company started trading in double-digits after a long time.

During tough times, Tilray (TLRY) looks overseas to achieve growth targets

Cannabis was recognized as an essential business in several markets when the shutdown came into effect, including Canada and some US states, at a time when its legalization is getting

Eastman Kodak (KODK) swings to a loss in Q2 2020; revenue drops 31%

Eastman Kodak (NYSE: KODK) reported a loss of $5 million on revenue of $213 million in the second quarter of 2020. The company earned $201 million in the prior-year quarter.

Top